Stevanato Group S.p.A. $STVN Shares Sold by Cooper Investors PTY Ltd.

Cooper Investors PTY Ltd. trimmed its holdings in Stevanato Group S.p.A. (NYSE:STVN) by 22.6% in the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 517,487 shares of the company’s stock after selling 151,007 shares during the period. Stevanato Group accounts for about 5.8% of Cooper Investors PTY Ltd.’s holdings, making the stock its 4th biggest holding. Cooper Investors PTY Ltd.’s holdings in Stevanato Group were worth $10,857,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also recently modified their holdings of the company. Fifth Third Bancorp lifted its stake in shares of Stevanato Group by 22.6% in the first quarter. Fifth Third Bancorp now owns 4,196 shares of the company’s stock worth $58,000 after buying an additional 773 shares in the last quarter. Integrated Wealth Concepts LLC purchased a new stake in Stevanato Group during the 2nd quarter valued at about $59,000. Hardy Reed LLC purchased a new stake in Stevanato Group during the 1st quarter valued at about $147,000. Diversify Wealth Management LLC raised its holdings in Stevanato Group by 23.9% in the 1st quarter. Diversify Wealth Management LLC now owns 18,353 shares of the company’s stock valued at $252,000 after acquiring an additional 3,543 shares during the last quarter. Finally, First Bank & Trust raised its holdings in Stevanato Group by 3.4% in the 2nd quarter. First Bank & Trust now owns 18,417 shares of the company’s stock valued at $333,000 after acquiring an additional 603 shares during the last quarter.

Insider Activity

In other Stevanato Group news, Director Luciano Santel sold 2,023 shares of Stevanato Group stock in a transaction dated Friday, August 7th. The shares were sold at an average price of €20.09, for a total transaction of €40,642.07. Following the transaction, the director directly owned 4,739 shares of the company’s stock, valued at €95,206.51. The trade was a 29.92% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, CFO Marco Dal Lago sold 4,209 shares of the business’s stock in a transaction dated Friday, August 7th. The shares were sold at an average price of €20.09, for a total transaction of €84,558.81. Following the completion of the transaction, the chief financial officer owned 81,144 shares in the company, valued at €1,630,182.96. The trade was a 4.93% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders sold 21,926 shares of company stock valued at $459,738 over the last three months. 0.70% of the stock is currently owned by company insiders.

Wall Street Analysts Forecast Growth

A number of research analysts have weighed in on the stock. TD Cowen raised shares of Stevanato Group to a “strong-buy” rating in a research note on Wednesday, June 17th. UBS Group started coverage on Stevanato Group in a report on Wednesday, September 9th. They set a “neutral” rating and a $23.00 target price on the stock. Deutsche Bank Aktiengesellschaft started coverage on Stevanato Group in a research report on Wednesday, October 7th. They issued a “hold” rating for the company. Finally, Weiss Ratings raised Stevanato Group from a “hold (c-)” rating to a “hold (c)” rating in a report on Thursday, August 27th. Two equities research analysts have rated the stock with a Strong Buy rating, two have given a Buy rating and four have given a Hold rating to the stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy”.

Stevanato Group Trading Down 0.2%

Shares of NYSE STVN traded down €0.04 during trading on Tuesday, hitting €19.20. 398,475 shares of the company were exchanged, compared to its average volume of 501,411. Stevanato Group S.p.A. has a 12-month low of €12.89 and a 12-month high of €27.99. The company has a debt-to-equity ratio of 0.21, a quick ratio of 1.08 and a current ratio of 1.61. The company has a fifty day moving average price of €21.03 and a 200-day moving average price of €18.68. The firm has a market capitalization of $5.81 billion, a PE ratio of 34.28, a P/E/G ratio of 1.59 and a beta of 0.78.

Stevanato Group (NYSE:STVN) last announced its quarterly earnings results on Wednesday, August 5th. The company reported €0.14 earnings per share for the quarter, missing the consensus estimate of €0.15 by (€0.01). Stevanato Group had a net margin of 10.99% and a return on equity of 10.43%. The firm had revenue of €302.00 million for the quarter. As a group, equities research analysts expect that Stevanato Group S.p.A. will post 0.69 EPS for the current year.

About Stevanato Group

Stevanato Group S.p.A. is an Italy-based provider of drug-containment, drug-delivery and diagnostic solutions for the pharmaceutical, biotechnology and healthcare industries. The company serves customers across the development, production and administration of injectable medicines, with activities spanning pharmaceutical glass packaging, medical devices and manufacturing technologies.

Its product portfolio includes glass vials, cartridges, syringes and other primary containers, as well as ready-to-use packaging solutions such as EZ-fill.